Matches in Wikidata for { <http://www.wikidata.org/entity/Q65316689> ?p ?o ?g. }
Showing items 1 to 46 of
46
with 100 items per page.
- Q65316689 description "assaig clínic" @default.
- Q65316689 description "clinical trial" @default.
- Q65316689 description "clinical trial" @default.
- Q65316689 description "clinical trial" @default.
- Q65316689 description "clinical trial" @default.
- Q65316689 description "ensaio clínico" @default.
- Q65316689 description "ensayo clínico" @default.
- Q65316689 description "ensayu clínicu" @default.
- Q65316689 description "essai clinique" @default.
- Q65316689 description "klinisch onderzoek" @default.
- Q65316689 description "клінічне випробування" @default.
- Q65316689 name "Dapagliflozin on Hyperlipidemia and Insulin Resistance in Type 2 Diabetic Patients (DAPHNIS Study)" @default.
- Q65316689 name "Dapagliflozin on Hyperlipidemia and Insulin Resistance in Type 2 Diabetic Patients" @default.
- Q65316689 type Item @default.
- Q65316689 label "Dapagliflozin on Hyperlipidemia and Insulin Resistance in Type 2 Diabetic Patients (DAPHNIS Study)" @default.
- Q65316689 label "Dapagliflozin on Hyperlipidemia and Insulin Resistance in Type 2 Diabetic Patients" @default.
- Q65316689 prefLabel "Dapagliflozin on Hyperlipidemia and Insulin Resistance in Type 2 Diabetic Patients (DAPHNIS Study)" @default.
- Q65316689 prefLabel "Dapagliflozin on Hyperlipidemia and Insulin Resistance in Type 2 Diabetic Patients" @default.
- Q65316689 P1050 Q65316689-8762F2CE-FF63-4522-B469-9E28E5C6195A @default.
- Q65316689 P1132 Q65316689-5D03F472-D336-48DD-AFF3-932502D7D5F2 @default.
- Q65316689 P1476 Q65316689-3F952A3F-3A46-42F7-AFC2-8F9C8106CEDE @default.
- Q65316689 P17 Q65316689-D132C8E8-FD42-4DBD-AB39-6425F60B2746 @default.
- Q65316689 P1813 Q65316689-29A0F23C-F963-41F3-AA95-534112339B6D @default.
- Q65316689 P2899 Q65316689-496D3583-125E-48E4-8CBF-6D20208C4F0A @default.
- Q65316689 P3098 Q65316689-47508103-C200-4640-AD54-410D49F63A17 @default.
- Q65316689 P31 Q65316689-35A4EADA-9BE7-4BA1-A71B-6A4CF671B07B @default.
- Q65316689 P4135 Q65316689-AEE34105-FD35-4A0E-B69E-5FEC66A4B791 @default.
- Q65316689 P580 Q65316689-4B213120-3611-41B4-BD28-09A68E62FC87 @default.
- Q65316689 P582 Q65316689-CCBB7B9B-5163-426B-9DD8-04EE804EC5F1 @default.
- Q65316689 P6099 Q65316689-0EF79044-3344-47D5-A536-ED66278096A1 @default.
- Q65316689 P6153 Q65316689-D61EBB7C-E574-4D7B-84BD-45935B28D6FB @default.
- Q65316689 P8363 Q65316689-76C49C6C-C1B6-4ACB-8778-F949C1A1AD37 @default.
- Q65316689 P1050 Q12206 @default.
- Q65316689 P1132 "+50" @default.
- Q65316689 P1476 "Effects of Dapagliflozin on Hyperlipidemia, Glycemic Control and Insulin Resistance in Type 2 Diabetic Patients (DAPHNIS Study)" @default.
- Q65316689 P17 Q17 @default.
- Q65316689 P1813 "DAPHNIS" @default.
- Q65316689 P2899 "+20" @default.
- Q65316689 P3098 "NCT02577159" @default.
- Q65316689 P31 Q30612 @default.
- Q65316689 P4135 "+65" @default.
- Q65316689 P580 "2015-07-01T00:00:00Z" @default.
- Q65316689 P582 "2017-12-31T00:00:00Z" @default.
- Q65316689 P6099 Q42825046 @default.
- Q65316689 P6153 Q651233 @default.
- Q65316689 P8363 Q78089383 @default.